These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12496444)

  • 1. Repression of bleomycin-induced pneumopathy by TNF.
    Kuroki M; Noguchi Y; Shimono M; Tomono K; Tashiro T; Obata Y; Nakayama E; Kohno S
    J Immunol; 2003 Jan; 170(1):567-74. PubMed ID: 12496444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
    Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
    J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
    Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
    Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
    Verma R; Brahmankar M; Kushwah L; Suresh B
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis.
    Kimura T; Ishii Y; Morishima Y; Shibuya A; Shibuya K; Taniguchi M; Mochizuki M; Hegab AE; Sakamoto T; Nomura A; Sekizawa K
    J Immunol; 2004 May; 172(9):5782-9. PubMed ID: 15100325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
    Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
    Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice.
    Kurokawa S; Suda M; Okuda T; Miyake Y; Matsumura Y; Ishimura M; Saito R; Nakamura T
    Pulm Pharmacol Ther; 2010 Oct; 23(5):425-31. PubMed ID: 20457270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
    Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis.
    Addis-Lieser E; Köhl J; Chiaramonte MG
    J Immunol; 2005 Aug; 175(3):1894-902. PubMed ID: 16034133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of IL-4 in lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Phan SH
    J Immunol; 2003 Feb; 170(4):2083-92. PubMed ID: 12574379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
    Kalayarasan S; Sriram N; Sudhandiran G
    Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
    Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
    J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
    Piguet PF; Collart MA; Grau GE; Kapanci Y; Vassalli P
    J Exp Med; 1989 Sep; 170(3):655-63. PubMed ID: 2475571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice.
    Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T
    Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
    Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
    Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
    J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12.
    Maeyama T; Kuwano K; Kawasaki M; Kunitake R; Hagimoto N; Hara N
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1128-37. PubMed ID: 11350791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.